Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has recently made a career move to…
Browsing: Lilly
Peter Marks, the former top FDA vaccine official who recently resigned, has joined Eli Lilly as the senior vice president…
When the FDA removed Novo Nordisk and Eli Lilly’s GLP-1 medications from the drug shortage list, it seemed like compounded…
Eli Lilly announced on Thursday that it will be implementing price increases for its medications in Europe and other developed…
Eli Lilly Makes Billion-Dollar Bet on Non-Opioid Pain Drugs Eli Lilly is making a bold move by investing up to…
This ban would have devastating consequences for the transgender community, denying them access to necessary gender-affirming care. Studies have shown…
This new oral semaglutide drug would be a game-changer for Novo Nordisk, potentially giving them an edge over Lilly in…
Indianapolis-based Eli Lilly Files Lawsuits Against Compounders Over Unapproved Products Eli Lilly, a pharmaceutical giant based in Indianapolis, has taken…
Novo Nordisk Makes Bold Move in Obesity Market with New Triple Agonist Danish biopharma giant Novo Nordisk is making waves…
The FDA’s recent decisions regarding compound GLP-1s have had a significant impact on the obesity drug market, particularly for pharma…
